Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Simon Fraser University

$64,000.00

Regulation of gene expression by bHLHPAS protein transcriptional complexes

EF 2022-23

Résumé
I am a molecular biologist with a desire to determine the molecular mechanisms of gene regulation by cellular multi-protein machines. We have characterized a transcriptional complex consisting of hypoxia-inducible factor1 (HIF), the aryl hydrocarbon receptor nuclear translocator (ARNT), the thyroid hormone receptor/retinoblastoma protein interacting protein-230 (TRIP230), and the retinoblastoma protein (Rb) involved in the regulation of specific sets of genes responsible for development, cellular transformation adaptation to low oxygen, and tissue damage. We have ablated Rb in human cell lines and found that genetic programs regulating tissue development, cellular motility and adaptive responses are sensitive to loss of Rb in a hypoxia-dependent fashion. A significant proportion of these genes are clustered on chromosomes suggesting that this complex regulates chromatin organization, thereby affecting specific genetic programs.I propose to expand our previous findings by focusing on how the hypoxia-inducible multi-protein complex regulates gene transcription and affects the outcomes of adaptive cellular responses and malignant transformation. Specifically, my short-term goal is to elucidate the means by which the hypoxia-inducible factor-/ (HIF1-ARNT) co-regulatory complex directs the expression of specific genetic programs and regulate chromatin organization. The specific aims of this proposal are;(1) To identify and characterize proteins mediating the HIF-ARNT_TRIP-Rb (HATR) complex activity. Factors recruited by Rb to attenuate the hypoxic response represent novel targets to manipulate genetic programs that regulate cell differentiation and adaptation to environmental stress. (2). To analyze long-term hypoxia-dependent gene silencing and de-repression after loss of Rb. Elucidation of the molecular mechanisms underlying Rb regulated HIF adaptive responses will enable us to identify malleable targets to remediate Rb loss. (3) To define the cistrome (DNA binding sites) of the HATR complex.This strategy will identify down-stream effectors of the biological responses regulated by the HATR complex and the manner in which it controls chromatin organization. These aims are novel in that they define a new role for a transcriptional complex known to be involved in the biology of cell development, adaptive responses to environmental stimuli and many pathological conditions. Following this strategy, we will in five years, have; (i) a realistic understanding of how the HATR complex directs specific genetic programs to regulate adaptive responses, and: (ii) identified protein targets regulating the HATR complex, its function and responses. These targets may be manipulated in the future to develop a more rational and targeted therapeutic approach to a number of pathologies including those involving cellular transformation.
Programme
Discovery Grants Program - Individual
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2018-05173
Name nom
Beischlag, Timothy
Department département
Health Sciences, Faculty of - Health Sciences, Faculty of
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2018
Award amount
64000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5300
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Molecular biology
Research subject fr
Biologie moléculaire
Installment
inst:5;6
Partie
2
Nb partie
6
Application title
Regulation of gene expression by bHLHPAS protein transcriptional complexes
Application summary
I am a molecular biologist with a desire to determine the molecular mechanisms of gene regulation by cellular multi-protein machines. We have characterized a transcriptional complex consisting of hypoxia-inducible factor1 (HIF), the aryl hydrocarbon receptor nuclear translocator (ARNT), the thyroid hormone receptor/retinoblastoma protein interacting protein-230 (TRIP230), and the retinoblastoma protein (Rb) involved in the regulation of specific sets of genes responsible for development, cellular transformation adaptation to low oxygen, and tissue damage. We have ablated Rb in human cell lines and found that genetic programs regulating tissue development, cellular motility and adaptive responses are sensitive to loss of Rb in a hypoxia-dependent fashion. A significant proportion of these genes are clustered on chromosomes suggesting that this complex regulates chromatin organization, thereby affecting specific genetic programs.I propose to expand our previous findings by focusing on how the hypoxia-inducible multi-protein complex regulates gene transcription and affects the outcomes of adaptive cellular responses and malignant transformation. Specifically, my short-term goal is to elucidate the means by which the hypoxia-inducible factor-/ (HIF1-ARNT) co-regulatory complex directs the expression of specific genetic programs and regulate chromatin organization. The specific aims of this proposal are;(1) To identify and characterize proteins mediating the HIF-ARNT_TRIP-Rb (HATR) complex activity. Factors recruited by Rb to attenuate the hypoxic response represent novel targets to manipulate genetic programs that regulate cell differentiation and adaptation to environmental stress. (2). To analyze long-term hypoxia-dependent gene silencing and de-repression after loss of Rb. Elucidation of the molecular mechanisms underlying Rb regulated HIF adaptive responses will enable us to identify malleable targets to remediate Rb loss. (3) To define the cistrome (DNA binding sites) of the HATR complex.This strategy will identify down-stream effectors of the biological responses regulated by the HATR complex and the manner in which it controls chromatin organization. These aims are novel in that they define a new role for a transcriptional complex known to be involved in the biology of cell development, adaptive responses to environmental stimuli and many pathological conditions. Following this strategy, we will in five years, have; (i) a realistic understanding of how the HATR complex directs specific genetic programs to regulate adaptive responses, and: (ii) identified protein targets regulating the HATR complex, its function and responses. These targets may be manipulated in the future to develop a more rational and targeted therapeutic approach to a number of pathologies including those involving cellular transformation.